Enable Accessibility Enable Accessibility

Delivering for patients with GI conditions

At Takeda, we are guided by our steadfast commitment to put the patient first in everything we do. In support of the gastrointestinal (GI) community, we support several programmes dedicated to education and awareness to ensure people living with GI conditions receive the care and support they need. This includes:

  • "In My Shoes" app created in partnership with Crohn’s and Colitis UK
  • "500,000 Reasons Why" campaign working with the community to raise awareness around the need for more consistent care for IBD patients across the UK
  • Our ACTIVATE programme to support professional development of early career doctors and pharmacists
  • IBD Empower to support professional development of nurses in their delivery of high quality care

In My Shoes App

As part of our work to raise awareness of IBD, we partnered with Crohn’s and Colitis UK to develop an immersive app titled “In My Shoes”. The app allows anyone to experience over 24 hours what it’s like to live with Crohn’s or ulcerative colitis – the main two forms of IBD. From depleting energy levels to managing pain, from rushing to the toilet to juggling work and a social life, the app enables people to see first- hand how the condition can affect everyday life. For more information and to download the app yourself, visit: https://www.ittakesguts.org.uk/share/in-my-shoes-app 



IMS logo.png

android phone.jpg

500,000 Reasons Why campaign

image: it is estimated that over 500,000 people are living with IBD in the UK.

As things stand, patients with long-term conditions receive varying standards of care from diagnosis through to treatment based on where they live. For those living with IBD, this variation across the patient pathway affects how long they wait to receive care, whether they have access to the right services, the quality of care they receive, and the quality of life they have.

We believe there is an urgent need to level the playing field for those living with a long-term condition, such as IBD. That is why we launched the 500,000 Reasons Why campaign to raise awareness for the need for more consistent care for IBD patients across the UK; ensuring national standards are implemented across the health system to have a positive effect on IBD care and patient quality of life.

As part of the campaign, Takeda hosted two roundtable events, published regional infographics detailing the standards of care across England, supported World IBD Day and launched two reports exploring key issues for people living with IBD:

  • The Economic Cost of Inflammatory Bowel Disease in the UK, which looked to demonstrate the urgent need for the greater prioritisation of IBD by the Government and health services, presenting the full socioeconomic impact of IBD – beyond just the health service and delving into its impact on patients’ lives and on the economy.

Watch Louise's video on life with IBD:

ACTIVATE: Developing the skills of Future Leaders in Inflammatory Bowel Disease to Improve Patient Care

ACTIVATE is a programme for HCPs only and may include mention of Takeda medicines

Activate is an award-winning educational programme co-created by Takeda and a group of expert healthcare professionals to provide unique, differentiated training to the IBD clinical community. This initiative offers support in developing a more flexible Leadership Style, navigating the NHS, writing effective business cases, working with commissioners, and developing presentation skills. ACTIVATE’s goal is to support the IBD community to improve care provided to IBD patients and create confident, active advocates for IBD.

For further detail on ACTIVATE, please contact UKandIEComms@takeda.com

IBD Empower

IBD Empower is an award-winning innovative, multi-channel disease-area education programme, for nurses by nurses, to support the professional growth of the IBD nursing community and improve patient care. This programme is delivered in three ways, through: live training sessions, an e-learning portal, and Lumi the innovative chatbot. Through these different learning styles, information is delivered in ways to support IBD CNS by furthering their skills and strengthening IBD patient care. Since being launched in October 2020, IBD Empower has already engaged with over 190 IBD CNS, many interacting with two or more channels, creating a blended learning experience. Through this, IBD Empower shows Takeda’s commitment to GI to provide support and create confidence with IBD nurses, allowing for greater patient care.

For further details on IBD Empower, please contact ibd.empower@takeda.com

Our commitment to the GI community

We are proud to work closely with the wider gastroenterology community, which includes being active members in British Society of Gastroenterology (BSG), BAPEN and working in partnership with key patient groups such as Crohn's & Colitis UK, PINNT and SBS & Friends. We also hold regular regional and local educational sessions and roundtables different members of the GI multidisciplinary team to foster ongoing education and networking.

For further details, or to share your comments on Takeda's commitment to GI patients and the community, please contact UKandIEComms@takeda.com

 

C-ANPROM/GB/CORP/0101
October 2022